Eurofarma Laboratórios S.A. Stock

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo Other stock markets			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Latest news : Eurofarma Laboratórios S.A.

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/10/25	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
21/10/25	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
22/08/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
16/05/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
27/03/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/03/25	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
15/11/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
14/08/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	23/11/2021
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	23/11/2021

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	23/11/2021
Cristina Presz Palmaka de Luca BRD	Director/Board Member	57	23/11/2021
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	01/01/2019

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
10/01/25	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
04/12/24	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%
04/12/24	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.17B 1.9B 1.77B 1.62B 3.05B 209B 3.1B 21.01B 8.21B 103B 8.13B 7.96B 355B	12.48B 2.46B 2.16B 2.01B 1.85B 3.47B 237B 3.52B 23.89B 9.33B 117B 9.25B 9.05B 403B
Net income	117M 23.15M 20.34M 18.91M 17.35M 32.61M 2.23B 33.11M 225M 87.74M 1.1B 86.92M 85.04M 3.79B	571M 113M 99.08M 92.15M 84.56M 159M 10.86B 161M 1.09B 427M 5.34B 423M 414M 18.47B
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company

Income Statement and Estimates

More financial data